TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,555
|
3,470
|
3,856 |
| Financial expenses |
30
|
24
|
8 |
| Earnings before taxes |
121
|
134
|
454 |
| EBITDA |
484
|
388
|
636 |
| Total assets |
2,974
|
2,618
|
3,179 |
| Current assets |
1,402
|
1,308
|
1,844 |
| Current liabilities |
688
|
653
|
1,245 |
| Equity capital |
1,747
|
1,708
|
1,594 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.7%
|
65.2%
|
50.1% |
| Turnover per employee |
1,185
|
1,157
|
1,285 |
| Profit as a percentage of turnover |
3.4%
|
3.9%
|
11.8% |
| Return on assets (ROA) |
5.1%
|
6.0%
|
14.5% |
| Current ratio |
203.8%
|
200.3%
|
148.1% |
| Return on equity (ROE) |
6.9%
|
7.8%
|
28.5% |
| Change turnover |
200
|
-406
|
-3 |
| Change turnover % |
6%
|
-10%
|
0% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-25% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.